Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Creese

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Alzheimer'S Research & Therapy|January 6, 2022
Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's diseaseByron Creese, Zahinoor Ismail
Nature Reviews. Neurology|September 16, 2022
Neuropsychiatric symptoms in AD: the search for mechanismsByron Creese, Katie Lunnon
Dementia and Geriatric Cognitive Disorders|February 9, 2013
Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic reviewByron Creese, Clive Ballard, Emma Jones
The Lancet. Neurology|June 21, 2017
A new tool to identify patients with Parkinson's disease at increased risk of dementiaDag Aarsland, Byron Creese, K Ray Chaudhuri
Expert Opinion on Drug Safety|August 6, 2010
Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortalityClive Ballard, Byron Creese, Anne Corbett, et al.
Current Treatment Options in Neurology|February 14, 2012
Treatment of behavioral and psychological symptoms of Alzheimer's diseaseAnne Corbett, Jessica Smith, Byron Creese, et al.
Journal of the American Medical Directors Association|October 13, 2014
Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer diseaseByron Creese, Anne Corbett, Emma Jones, et al.
Expert Review of Neurotherapeutics|May 17, 2018
The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's diseaseByron Creese, Miguel Vasconcelos Da Silva, Iskandar Johar, et al.
Cognitive, Affective & Behavioral Neuroscience|March 27, 2026
Neuropsychiatric symptoms and their impact on cognitive functioning in patients with parkinson's disease: A systematic review of the literatureBarbara Blasutto, Giulia Matrone, Byron Creese, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 16, 2013
Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementiasByron Creese, Clive Ballard, Dag Aarsland, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Alzheimer'S Research & Therapy|January 6, 2022
Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's diseaseByron Creese, Zahinoor Ismail
Nature Reviews. Neurology|September 16, 2022
Neuropsychiatric symptoms in AD: the search for mechanismsByron Creese, Katie Lunnon
Dementia and Geriatric Cognitive Disorders|February 9, 2013
Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic reviewByron Creese, Clive Ballard, Emma Jones
The Lancet. Neurology|June 21, 2017
A new tool to identify patients with Parkinson's disease at increased risk of dementiaDag Aarsland, Byron Creese, K Ray Chaudhuri
Expert Opinion on Drug Safety|August 6, 2010
Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortalityClive Ballard, Byron Creese, Anne Corbett, et al.
Current Treatment Options in Neurology|February 14, 2012
Treatment of behavioral and psychological symptoms of Alzheimer's diseaseAnne Corbett, Jessica Smith, Byron Creese, et al.
Journal of the American Medical Directors Association|October 13, 2014
Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer diseaseByron Creese, Anne Corbett, Emma Jones, et al.
Expert Review of Neurotherapeutics|May 17, 2018
The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's diseaseByron Creese, Miguel Vasconcelos Da Silva, Iskandar Johar, et al.
Cognitive, Affective & Behavioral Neuroscience|March 27, 2026
Neuropsychiatric symptoms and their impact on cognitive functioning in patients with parkinson's disease: A systematic review of the literatureBarbara Blasutto, Giulia Matrone, Byron Creese, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 16, 2013
Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementiasByron Creese, Clive Ballard, Dag Aarsland, et al.
Pageof 11